Excelsior Medical Revenue and Competitors

USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Excelsior Medical's estimated annual revenue is currently $33.1M per year.(i)
  • Excelsior Medical's estimated revenue per employee is $251,000

Employee Data

  • Excelsior Medical has 132 Employees.(i)
  • Excelsior Medical grew their employee count by -4% last year.

Excelsior Medical's People

NameTitleEmail/Phone
1
Warehouse And Distribution ManagerReveal Email/Phone
2
Filling and Sterilization ManagerReveal Email/Phone
3
Production PlannerReveal Email/Phone
4
Purchasing AgentReveal Email/Phone
5
Sterilization - Production/Pacakging SupervisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Excelsior Medical?

Excelsior Medical, LLC is one of the leading manufacturers of pre-filled saline and heparin flush syringes as well as syringe pump and pharmacy dispensing pump systems. Excelsior also developed and manufacturers SwabCap® and SwabFlush®. SwabCap is a sterile packaged disinfection cap designed to disinfect the top and threads of IV luer-lock needleless connectors with 70% isopropyl alcohol when attached to the connector hub. Caregivers simply luer-lock SwabCap on the connector aseptically and leave in place between line accesses to disinfect the connector and maintain a disinfected valve surface for up to 7 days if not removed. SwabFlush is the only device that combines a saline flush syringe and disinfection cap. This combination is designed to help improve compliance with disinfection protocols because SwabCap is built into the syringe plunger, making it immediately and conveniently available to nurses after they flush an I.V. line. SwabCap and SwabFlush have been the subject of numerous award-winning scientific presentations by independent clinician users at recent annual meetings of the Association for Vascular Access (AVA), Association for Professionals in Infection Control and Epidemiology (APIC), and the Children’s Hospital Association. The use of disinfection caps has been included in the new infection-control recommendations sponsored by SHEA.

keywords:N/A

N/A

Total Funding

132

Number of Employees

$33.1M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.5M13265%N/A
#2
$19.8M1326%N/A
#3
N/A1325%N/A
#4
$23.8M1329%N/A
#5
$30M132N/AN/A